郑重声明:斯道资本从没有通过微信、APP、网站或任何其他渠道以斯道资本名义进行任何此类活动,也没有授权任何实体或个人以斯道资本名义进行任何此类活动。斯道资本进一步声明其从不对外集资或募资,也不直接或间接销售任何投资理财产品,更不接受个人投资。

TreeENT completes Series A funding
Our China Ventures team has invested in TreeENT Health, a Hangzhou-based eye, ears, nose, and throat (EENT) day surgery operator.

Eight Roads sister fund, F-Prime, also participated. TreeENT will use the multi-million Series A funding round to open new facilities in the Yangtze River Delta region.

Day surgery is still a new practice in China, accounting for only 5% of EENT operations, compared 70% in Europe and the US. TreeENT looks to fill the market gap with cutting-edge medical device and by offering personalised treatment plans with medical experts. The development of day surgery is supported by the Chinese government.

TreeENT opened its first day surgery centre in Hangzhou, Zhejiang Province in July 2017. As of the end of 2018, TreeENT had already served nearly 100,000 patients.

分享